Circurna
PrivateLast Round
Seed
Nov 1, 2025
Total Funding Raised
$4.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Circurna (formerly Emervax) is a biotechnology company developing next-generation vaccines and therapeutics using a proprietary circular RNA platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Circurna Comparables
Compare Circurna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sail Biomedicines | 85% | |
| CircNova | 85% | |
| Shanghai CirCode Biomed Co. Ltd. | 82% | |
Circurna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2025 | ||||
| Series A | Aug 25, 2025 | ||||
| Grant | Jan 23, 2024 | ||||
| Grant | Oct 24, 2023 |
Key People
Founding team and executive leadership
Circurna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| DHSC | Grant |
| Innovate UK Contracts for Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 60% QoQ from 5 to 8 employees.
- Jan 22, 2026
Grew 60% QoQ, from 5 to 8 employees.
Circurna Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |